Person › Details

Ron O’Brien (Thermo Fisher Scientific Inc. (NYSE: TMO))

O’Brien, Ron (Thermo Fisher 201003 Director Public Relations)

	Organisation	Thermo Fisher Scientific Inc. (NYSE: TMO)
	Group	Thermo Fisher (Group)
	Product	laboratory equipment and instruments
	Product 2	reagents (bio/biochemical)

Thermo Fisher Scientific Inc.. (3/5/10). "Press Release: Thermo Fisher Scientific Completes Acquisition of Finnzymes". Waltham, MA.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has completed its previously announced acquisition of Finnzymes. The business is a well-recognized provider of integrated tools for high-performance polymerase chain reaction (PCR), including reagents, instruments, consumables and kits that make the PCR process faster and more accurate for applications including basic genomic research, genetic testing, forensics and food safety.

Finnzymes, which generated full year 2009 revenues of $20 million, will be integrated primarily into Thermo Fisher's Analytical Technologies Segment, with certain equipment and consumables product lines being added to the Laboratory Products and Services Segment.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.

Thermo Fisher Scientific

Media Contact Information:
Ron O'Brien, 781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com

or

Investor Contact Information:
Ken Apicerno, 781-622-1111
ken.apicerno@thermofisher.com

Record changed: 2012-04-30

Follow Us!

Top News

Upcoming Events

Associations

Partners

Ron O’Brien (Thermo Fisher Scientific Inc. (NYSE: TMO))

Thermo Fisher Scientific Inc.. (3/5/10). "Press Release: Thermo Fisher Scientific Completes Acquisition of Finnzymes". Waltham, MA.

More documents for Ron O’Brien